Literature DB >> 1471872

The free radical hypothesis in idiopathic parkinsonism: evidence against it.

D B Calne1.   

Abstract

The free radical hypothesis for the pathogenesis of idiopathic parkinsonism (Parkinson's disease) has many similarities to the argument invoking an autoimmune mechanism. In both cases, cellular and molecular machinery that might be involved in neuronal destruction have been demonstrated. In recent years, the free radical hypothesis has become particularly fashionable; several workers have reported observations which, they infer, support the notion that damage by free radicals is a major factor in the underlying disease process. There is, however, no conclusive evidence that free radicals play a prominent role in the causal chain of events that leads to idiopathic parkinsonism; several findings may be construed as evidence against such a contention.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471872     DOI: 10.1002/ana.410320615

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.

Authors:  Bevyn Jarrott; Spencer J Williams
Journal:  Neurochem Res       Date:  2015-07-16       Impact factor: 3.996

2.  Selegiline in Parkinson's disease.

Authors:  D B Calne
Journal:  BMJ       Date:  1995-12-16

3.  Parkinson's Disease: Initial Treatment with Levodopa or Dopamine Agonists.

Authors:  Stewart A. Factor
Journal:  Curr Treat Options Neurol       Date:  2001-11       Impact factor: 3.598

Review 4.  Treatment of Parkinson's disease.

Authors:  M J Aminoff
Journal:  West J Med       Date:  1994-09

Review 5.  Iron in chronic brain disorders: imaging and neurotherapeutic implications.

Authors:  James Stankiewicz; S Scott Panter; Mohit Neema; Ashish Arora; Courtney E Batt; Rohit Bakshi
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

Review 6.  Idiopathic Parkinson's disease: epidemiology, diagnosis and management.

Authors:  Y Ben-Shlomo; K Sieradzan
Journal:  Br J Gen Pract       Date:  1995-05       Impact factor: 5.386

7.  MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease.

Authors:  Paraskevi Kosta; Maria I Argyropoulou; Sofia Markoula; Spyridon Konitsiotis
Journal:  J Neurol       Date:  2005-06-29       Impact factor: 6.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.